The founding director of the Taubman Institute, Eva L. Feldman, MD, PhD, has been honored with a professorship in her name, established by longtime institute benefactor Edith Briskin.
Dr. Feldman, the James W. Albers Distinguished University Professor and Russell N. DeJong Professor of Neurology, is known internationally for her groundbreaking research and leadership across neurological disorders like amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, as well as cognitive and neuropathic complications related to diabetes and obesity.
Mrs. Briskin, Drs. Callaghan and Feldman
In 2008, she launched the institute in 2008 with a gift from philanthropist A. Alfred Taubman, to support translational research by U-M’s talented physician-researchers. To date, nearly 60 clinician-scientists have benefited from financial grants, research collaboration, mentorship and other support from the Taubman community.
Since completing her 10-year term as institute director, Dr. Feldman has continued myriad other endeavors, including growing her own research program, the Neuronetwork for Emerging Therapies, now in its 23rd year.
Mrs. Briskin has long lent her support to the institute, and was instrumental in establishing the Taubman Emerging Scholars program that has provided funding and mentorship to early-career physician-researchers.
Brian Callaghan, MD, MS, will be the inaugural recipient of the neurology professorship that honors Dr. Feldman. Dr. Callaghan serves as co-director of the Neuromuscular division at Michigan Medicine and Associate Program Director of Research for the Neurology Residency Program, as well as in a staff physician at the Ann Arbor Veterans Affairs Hospital, running its ALS Clinic.
Internationally known for his expertise in peripheral neuropathy, pain management, and healthcare policy, he has produced more than 125 publications.
The Taubman Institute sends warm congratulations and thanks to Dr. Feldman, Mrs. Briskin and Dr. Callaghan.
